Breaking News

20 October 2008
Results disclosed from PHOENIX 2 phase III study with ustekinumab in psoriasis
20 October 2008
Association factors for pediatric atopic dermatitis on Ishigaki Island
17 October 2008
Scoring skin disease severity in pediatric dermatology: Use of a new scale
16 October 2008
Prognostic factors in adults with atopic dermatitis
15 October 2008
Economic evaluation of maintenance treatment with tacrolimus ointment in adult atopic dermatitis
14 October 2008
Proactive tacrolimus ointment treatment for pediatric atopic dermatitis: A controlled study
13 October 2008
Development of soft calineurin inhibitors for atopic dermatitis reported
12 October 2008
Increased serum APRIL levels in patients with atopic dermatitis
11 October 2008
Efalizumab label changes address safety issues
10 October 2008
Serological markers of celiac disease in psoriasis patients
09 October 2008
Safety and efficacy of topical tacrolimus and pimecrolimus in the treatment of atopic dermatitis in patients previously treated with corticosteroids
08 October 2008
Defective killing of Staphylococcus aureus in atopic dermatitis is linked to decreased mobility of beta-defensin-3
07 October 2008
Pathophysiological roles of inducible heme oxygenase in atopic dermatitis
30 September 2008
Changes in the prevalence of pediatric atopic dermatitis from 1986-2001 in urban Copenhagen
29 September 2008
Tacrolimus and transformation growth factor beta act synergistically on Langerhans cell transformation
26 September 2008
CD40 expression and correlation with disease severity in atopic dermatitis
25 September 2008
Meta-analysis of systemic treatments for psoriasis
23 September 2008
Prognostic value of molecular and biochemical tests in stage III melanoma patients
23 September 2008
Clobetasone foam: A review of open-label and controlled trials in adult and pediatric dermatoses
22 September 2008
Managing itch-associated burns: A review